MYC and neoplasm: Consistent with their direct involvement in transcriptional activation of MHC-I AgPPM genes, ablation of p300 or RelA abrogated Tap1, Psmb9, and Nlrc5 induction in Myc-CaP tumors, but had no effect on tumor infiltration by effector CD8+ cells.